Literature DB >> 26788997

Key Issues Associated with Helicobacter pylori Eradication.

Takashi Kawai1, Fuminori Moriyasu, Akihiko Tsuchida.   

Abstract

Eradication of Helicobacter pylori causes improvement of gastric atrophy and intestinal metaplasia. Gastric acid secretion levels in corpus predominant gastritis increase after eradication. These changes can increase the risk of reflux esophagitis and low-dosage aspirin ulcers. Although eradication may reduce the overall risk of gastric cancer, a certain degree of risk remains, related to the extent of atrophy and intestinal metaplasia. Many post-eradication gastric cancers are the early depressed type, with low levels of epithelial atypia, and therefore can be difficult to distinguish endoscopically from benign erosion. Further research is required in this area.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26788997     DOI: 10.1159/000441667

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Lifestyle- and comorbidity-related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan.

Authors:  Furitsu Shimada; Hiroyoshi Endo; Ayako Takamori; Takuya Matsunaga; Shun Fujimoto; Shimpei Shirai; Toshihiko Kakiuchi; Takashi Akutagawa; Yasuhisa Sakata; Koichi Node; Kohei Yamanouchi; Shotaro Nakamura; Kazuma Fujimoto; Motohiro Esaki
Journal:  JGH Open       Date:  2021-11-10

2.  Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study.

Authors:  Jung-Nien Lai; Yi-Jun Liao; Cheng-Li Lin; Chi-Sen Chang; Yen-Chun Peng
Journal:  BMJ Open       Date:  2022-08-24       Impact factor: 3.006

3.  Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups.

Authors:  Tomomi Yoshioka; Eri Takeshita; Yasuhisa Sakata; Megumi Hara; Kayo Akutagawa; Natsuko Sakata; Hiroyoshi Endo; Takashi Ohyama; Keiji Matsunaga; Yuichiro Tanaka; Shinpei Shirai; Yoichiro Ito; Nanae Tsuruoka; Ryuichi Iwakiri; Motoyasu Kusano; Kazuma Fujimoto
Journal:  Esophagus       Date:  2017-03-15       Impact factor: 4.230

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.